MiR-181c-5p Mitigates Tumorigenesis in Cervical Squamous Cell Carcinoma via Targeting Glycogen Synthase Kinase 3β Interaction Protein (GSKIP).

Li N, Cheng C, Wang T

Open source

DOI
10.2147/ott.s245254
Published
2020
Container
OncoTargets and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ott.s245254,
  title = {MiR-181c-5p Mitigates Tumorigenesis in Cervical Squamous Cell Carcinoma via Targeting Glycogen Synthase Kinase 3β Interaction Protein (GSKIP).},
  author = {Li N and Cheng C and Wang T},
  year = {2020},
  journal = {OncoTargets and therapy},
  doi = {10.2147/ott.s245254},
  url = {https://doi.org/10.2147/ott.s245254}
}

RIS

TY  - JOUR
TI  - MiR-181c-5p Mitigates Tumorigenesis in Cervical Squamous Cell Carcinoma via Targeting Glycogen Synthase Kinase 3β Interaction Protein (GSKIP).
AU  - Li N
AU  - Cheng C
AU  - Wang T
PY  - 2020
JO  - OncoTargets and therapy
DO  - 10.2147/ott.s245254
UR  - https://doi.org/10.2147/ott.s245254
ER  - 

APA

N, L., C, C., & T, W. (2020). MiR-181c-5p Mitigates Tumorigenesis in Cervical Squamous Cell Carcinoma via Targeting Glycogen Synthase Kinase 3β Interaction Protein (GSKIP).. OncoTargets and therapy. https://doi.org/10.2147/ott.s245254

Source records